Overview
Jun Nakata practices in Osaka, Japan. Mr. Nakata is rated as a Distinguished expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 54 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Wilms TumorMr. Nakata isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesMr. Nakata isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Familial Wilms Tumor 2Mr. Nakata isAdvanced. Learn about Familial Wilms Tumor 2.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Nakata isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AstrocytomaMr. Nakata isExperienced. Learn about Astrocytoma.
- Bone Marrow AspirationMr. Nakata isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantMr. Nakata isExperienced. Learn about Bone Marrow Transplant.
- Bronchiolitis ObliteransMr. Nakata isExperienced. Learn about Bronchiolitis Obliterans.
- Chronic Myelogenous Leukemia (CML)Mr. Nakata isExperienced. Learn about Chronic Myelogenous Leukemia (CML).